SUHEUNG CO.,LTD.
Financials
Valuation Metrics
SUHEUNG CO.,LTD.'s Market Cap is ₩2580B. At end of 2025 it was ₩2505B. Ranked #709 of 2,436 in KR market (top 29%), #412 of 787 on KOSPI (top 52%), #23 of 96 in Health Care Equipment & Services (top 24%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 257.99B KRW | KR#709/2,436 Sec#23/96 |
| Revenue | 743.02B KRW | KR#473/2,436 Sec#3/96 |
| Net Income | 55.03B KRW | KR#341/2,436 Sec#3/96 |
| Total Assets | 1.09T KRW | KR#447/2,436 Sec#4/96 |
| Net Assets | 556.40B KRW | KR#460/2,436 Sec#5/96 |
| Employees | 1,214 | KR#211/2,436 Sec#1/96 |
| Value | ||
| P/E | 4.69x | KR#237/2,436 Sec#4/96 |
| P/B | 0.46x | KR#686/2,436 Sec#10/96 |
| PEG | 0.04x | KR#220/2,436 Sec#8/96 |
| P/S | 0.35x | KR#659/2,436 Sec#3/96 |
| EV/EBITDA | 10.86x | KR#648/2,436 Sec#21/96 |
| FCF Yield | 12.12% | KR#534/2,436 Sec#8/96 |
| Profitability | ||
| ROE | 9.89% | KR#519/2,436 Sec#24/96 |
| ROA | 5.06% | KR#641/2,436 Sec#28/96 |
| Op. Margin | 8.06% | KR#615/2,436 Sec#32/96 |
| Revenue Growth | 11.45% | KR#868/2,436 Sec#40/96 |
| Earnings Growth | 118.91% | KR#378/2,436 Sec#16/96 |
| Financial Health | ||
| Debt Ratio | 195.48% | KR#1,680/2,436 Sec#79/96 |
| Total Debt | 445.74B KRW | KR#320/2,436 Sec#3/96 |
| FCF | 31.28B KRW | KR#407/2,436 Sec#5/96 |
| Cash | 53.26B KRW | KR#724/2,436 Sec#10/96 |
| Current Ratio | 1.22x | KR#1,555/2,436 Sec#76/96 |
| Net Debt/EBITDA | 6.55x | KR#1,167/2,436 Sec#44/96 |
| Dividend | ||
| Div. Yield | 2.40% | KR#792/2,436 Sec#16/96 |
| Div. Growth | 150.00% | KR#61/2,436 Sec#6/96 |
| Performance | ||
| 1Y Return | 18.55% | KR#473/2,436 Sec#12/96 |
| 1M Return | 16.27% | KR#221/2,436 Sec#13/96 |
| From 52W High | -31.60% | KR#543/2,436 Sec#18/96 |
| 1Y MDD | -47.91% | KR#829/2,436 Sec#27/96 |
| Trading | ||
| Volume | 57,005 shares | KR#1,542/2,436 Sec#65/96 |
| Foreign Own. | 7.49% | KR—/2,436 Sec—/96 |
| Per Share | ||
| EPS | 4,268 KRW | KR#203/2,436 Sec#2/96 |
| BPS | 45,022 KRW | KR#261/2,436 Sec#2/96 |
Company Info
Seoheung, established in 1973 and listed on the securities market in 1990, operates businesses in hard capsule manufacturing, contract manufacturing of soft capsule pharmaceuticals, health functional foods, and cosmetics. The company commands over 95% of the domestic hard capsule market and holds a third-place position globally. Leveraging over 50 years of capsule manufacturing expertise and the competitiveness of its patented EMBO CAPS, Seoheung is expanding its overseas market share through the expansion of its Vietnam factory. Seoheung is headquartered in Cheongju-si, Chungcheongbuk-do, and maintains various overseas and domestic affiliates.